The Survey Research and Data Acquisition Resource (SRDAR) is a new CCSG Resource thatoriginated out of the Cancer Prevention and Population Sciences Program in the summer of 2004. Themission of SRDAR is to provide a collaborative Resource within RPCI for data collection and study designservices for investigators from CCSG Programs. Collecting valid and reliable survey data is critical for allinvestigators. SRDAR data collection services include phone surveys, face-to-face interviews, clinical followupassessments, trial recruitment, web-based surveys, mail-based biologic data collection, scannable formsand focus groups. SRDAR can also provide assistance with protocol development and dissemination offindings. The personnel structure includes the Resource Director, scientific coordinator, administrativecoordinator, informatics coordinator and data collection staff (currently 30 FTE). Leading up to thedesignation as a CCSG Resource, RPCI contributed $167,520 in personnel and equipment expenses tocreate the SRDAR infrastructure. CCSG support will be used to defray these management expenses andchargebacks will cover 66% of the expected $1.1 million FY 2008 operating budget. Since its inception,SRDAR has supported 41 projects and generated $1.1 million in revenue; 51% has come from peerreviewedsources, including 40% from NIH grants. As a CCSG Resource, SRDAR will seek to expand itsrole in research in all CCSG Programs.The Resource is used by two Programs and 88% of users are CCSG members. $98,966 in CCSGsupport is requested, representing 9% of the total operating budget.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016056-32
Application #
7714432
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-07-28
Project End
2013-04-30
Budget Start
2008-07-28
Budget End
2009-04-30
Support Year
32
Fiscal Year
2008
Total Cost
$83,184
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Vexler, Albert; Yu, Jihnhee; Zhao, Yang et al. (2018) Expected p-values in light of an ROC curve analysis applied to optimal multiple testing procedures. Stat Methods Med Res 27:3560-3576
Mussell, Ashley L; Denson, Kayla E; Shen, He et al. (2018) Loss of KIBRA function activates EGFR signaling by inducing AREG. Oncotarget 9:29975-29984
Hirose, Yuki; Nagahashi, Masayuki; Katsuta, Eriko et al. (2018) Generation of sphingosine-1-phosphate is enhanced in biliary tract cancer patients and is associated with lymphatic metastasis. Sci Rep 8:10814
Kesterson, Joshua P; Szender, J Brian; Schaefer, Eric et al. (2018) Evaluation of Association Between Gynecologic Oncology Fellowship Length and a Career in Academic Medicine. J Cancer Educ 33:141-146
Samuel, Sandeep; Mukherjee, Sarbajit; Ammannagari, Nischala et al. (2018) Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study. PLoS One 13:e0198809
Yendamuri, Sai; Groman, Adrienne; Miller, Austin et al. (2018) Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer. Eur J Cardiothorac Surg 53:656-663
Miller, James A; Harris, Kassem; Roche, Charles et al. (2018) Sarcopenia is a predictor of outcomes after lobectomy. J Thorac Dis 10:432-440
Fenstermaker, Robert A; Figel, Sheila A; Qiu, Jingxin et al. (2018) Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth In Vivo. Clin Cancer Res 24:2642-2652
Bhat, Tariq A; Kalathil, Suresh Gopi; Bogner, Paul N et al. (2018) Secondhand Smoke Induces Inflammation and Impairs Immunity to Respiratory Infections. J Immunol 200:2927-2940
Merzianu, Mihai; Groman, Adrienne; Hutson, Alan et al. (2018) Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study. Am J Clin Pathol 150:393-405

Showing the most recent 10 out of 1555 publications